FDA to hold meeting on CAD fetal monitors

The FDA is seeking feedback on evaluating and improving the effectiveness of fetal monitors that use computer-aided detection (CAD) technology.

To evaluate the technology, the agency is holding a free all-day workshop on the subject on Nov. 10 at its Silver Spring, Md., campus.

Attendees will discuss how to identify and differentiate the various categories of the devices and the corresponding levels of evidence needed to validate them. Participants also will discuss how current databases might be used to verify and validate algorithms for the devices.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.